The global Drug Discovery Biosimulation Software market size is predicted to grow from US$ 1108 million in 2025 to US$ 2125 million in 2031; it is expected to grow at a CAGR of 11.5% from 2025 to 2031.
Drug discovery biosimulation software refers to a professional software tool that uses computer modeling, mathematical algorithms, and bioinformatics techniques to simulate and predict the interactions between drug molecules and biological systems (such as proteins, cells, tissues, or the entire organism). This type of software can predict the pharmacological activity, toxicity, and pharmacokinetic properties of candidate compounds in a virtual environment by establishing quantitative structure-activity relationships (QSAR), molecular dynamics simulations, systems biology models, and other methods, thereby significantly reducing the laboratory testing and animal experiments required in traditional drug discovery processes.
The global market for biosimulation software for drug discovery has shown a steady growth trend in recent years. Biological simulation technology can help pharmaceutical companies reduce research and development costs and shorten research and development cycles. The cost-benefit ratio is particularly important in the context of patent cliff and medical expenditure control. Regulatory agencies such as the US FDA and European EMA are increasingly accepting modeling and simulation data as auxiliary evidence for new drug applications. The integration of artificial intelligence algorithms, high-performance computing, and biological big data analysis has significantly improved the predictive accuracy and applicability of biological simulations, making them gradually become one of the core methods for drug discovery from auxiliary tools. The rise of precision medicine and personalized dosing regimens has increased the demand for patient specific simulations, driving the expansion of the application of biosimulation software in preclinical and clinical stages. North America currently holds the largest market share, followed by Europe and the Asia Pacific region. The market presents a diversified competitive pattern and moderate concentration characteristics. The main participants include well-known companies such as Biolauncher, Certara, Dassault Systemes, etc. Leading companies mainly maintain and expand their market position through technological innovation, strategic mergers and acquisitions, partnerships, and cloud service transformation. In the Chinese market, core technologies and high-end markets are still dominated by international giants, but local enterprises such as Tencent AI Lab and PharmaResources are gradually increasing their influence through independent research and development and strategic cooperation. In the future, the integration of artificial intelligence will become the most significant trend in technological development. The new generation of AI driven simulation tools can learn complex patterns from massive biomedical data and achieve higher precision predictions. The next generation of biological simulation software will have the ability to integrate and analyze multidimensional data such as genomics, proteomics, metabolomics, etc., and construct multi-scale models that are closer to real biological systems.
The 鈥淒rug Discovery Biosimulation Software Industry Forecast鈥� looks at past sales and reviews total world Drug Discovery Biosimulation Software sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Discovery Biosimulation Software sales for 2025 through 2031. With Drug Discovery Biosimulation Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Discovery Biosimulation Software industry.
This Insight Report provides a comprehensive analysis of the global Drug Discovery Biosimulation Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Discovery Biosimulation Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug Discovery Biosimulation Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Discovery Biosimulation Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Discovery Biosimulation Software.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Discovery Biosimulation Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
Molecular Modeling And Structural Prediction Software
Virtual Screening And Molecular Design Software
ADMET Prediction Software
Molecular Dynamics Simulation Software
Systems Biology And Multiscale Modeling Software
Others
Segmentation by Application:
Target Recognition
Virtual Screening
Lead Optimization
Pharmacokinetic Simulation
Toxic Predicting
Mechanism Analysis
Effect Analysis
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biolauncher
Pfizer
Dassault Systemes
Novartis
Schrodinger
AstraZeneca
Insilico Medicine
Simulations Plus
Molecular Networks
Evotec
Boehringer Ingelheim
Certara
Tencent AI Lab
PharmaResources
Quantum Hi-Tech (China) Biotechnology
Leto Laboratories
Zuoshouyisheng
Taimei Technology
AIxplorerbio
Moore Threads
StoneWise
NovaX Biotech
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Discovery Biosimulation Software Market Size (2020-2031)
2.1.2 Drug Discovery Biosimulation Software Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Drug Discovery Biosimulation Software by Country/Region (2020, 2024 & 2031)
2.2 Drug Discovery Biosimulation Software Segment by Type
2.2.1 Molecular Modeling And Structural Prediction Software
2.2.2 Virtual Screening And Molecular Design Software
2.2.3 ADMET Prediction Software
2.2.4 Molecular Dynamics Simulation Software
2.2.5 Systems Biology And Multiscale Modeling Software
2.2.6 Others
2.3 Drug Discovery Biosimulation Software Market Size by Type
2.3.1 Drug Discovery Biosimulation Software Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Drug Discovery Biosimulation Software Market Size Market Share by Type (2020-2025)
2.4 Drug Discovery Biosimulation Software Segment by Application
2.4.1 Target Recognition
2.4.2 Virtual Screening
2.4.3 Lead Optimization
2.4.4 Pharmacokinetic Simulation
2.4.5 Toxic Predicting
2.4.6 Mechanism Analysis
2.4.7 Effect Analysis
2.4.8 Others
2.5 Drug Discovery Biosimulation Software Market Size by Application
2.5.1 Drug Discovery Biosimulation Software Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Drug Discovery Biosimulation Software Market Size Market Share by Application (2020-2025)
3 Drug Discovery Biosimulation Software Market Size by Player
3.1 Drug Discovery Biosimulation Software Market Size Market Share by Player
3.1.1 Global Drug Discovery Biosimulation Software Revenue by Player (2020-2025)
3.1.2 Global Drug Discovery Biosimulation Software Revenue Market Share by Player (2020-2025)
3.2 Global Drug Discovery Biosimulation Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Discovery Biosimulation Software by Region
4.1 Drug Discovery Biosimulation Software Market Size by Region (2020-2025)
4.2 Global Drug Discovery Biosimulation Software Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug Discovery Biosimulation Software Market Size Growth (2020-2025)
4.4 APAC Drug Discovery Biosimulation Software Market Size Growth (2020-2025)
4.5 Europe Drug Discovery Biosimulation Software Market Size Growth (2020-2025)
4.6 Middle East & Africa Drug Discovery Biosimulation Software Market Size Growth (2020-2025)
5 Americas
5.1 Americas Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
5.2 Americas Drug Discovery Biosimulation Software Market Size by Type (2020-2025)
5.3 Americas Drug Discovery Biosimulation Software Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Discovery Biosimulation Software Market Size by Region (2020-2025)
6.2 APAC Drug Discovery Biosimulation Software Market Size by Type (2020-2025)
6.3 APAC Drug Discovery Biosimulation Software Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
7.2 Europe Drug Discovery Biosimulation Software Market Size by Type (2020-2025)
7.3 Europe Drug Discovery Biosimulation Software Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Discovery Biosimulation Software by Region (2020-2025)
8.2 Middle East & Africa Drug Discovery Biosimulation Software Market Size by Type (2020-2025)
8.3 Middle East & Africa Drug Discovery Biosimulation Software Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Discovery Biosimulation Software Market Forecast
10.1 Global Drug Discovery Biosimulation Software Forecast by Region (2026-2031)
10.1.1 Global Drug Discovery Biosimulation Software Forecast by Region (2026-2031)
10.1.2 Americas Drug Discovery Biosimulation Software Forecast
10.1.3 APAC Drug Discovery Biosimulation Software Forecast
10.1.4 Europe Drug Discovery Biosimulation Software Forecast
10.1.5 Middle East & Africa Drug Discovery Biosimulation Software Forecast
10.2 Americas Drug Discovery Biosimulation Software Forecast by Country (2026-2031)
10.2.1 United States Market Drug Discovery Biosimulation Software Forecast
10.2.2 Canada Market Drug Discovery Biosimulation Software Forecast
10.2.3 Mexico Market Drug Discovery Biosimulation Software Forecast
10.2.4 Brazil Market Drug Discovery Biosimulation Software Forecast
10.3 APAC Drug Discovery Biosimulation Software Forecast by Region (2026-2031)
10.3.1 China Drug Discovery Biosimulation Software Market Forecast
10.3.2 Japan Market Drug Discovery Biosimulation Software Forecast
10.3.3 Korea Market Drug Discovery Biosimulation Software Forecast
10.3.4 Southeast Asia Market Drug Discovery Biosimulation Software Forecast
10.3.5 India Market Drug Discovery Biosimulation Software Forecast
10.3.6 Australia Market Drug Discovery Biosimulation Software Forecast
10.4 Europe Drug Discovery Biosimulation Software Forecast by Country (2026-2031)
10.4.1 Germany Market Drug Discovery Biosimulation Software Forecast
10.4.2 France Market Drug Discovery Biosimulation Software Forecast
10.4.3 UK Market Drug Discovery Biosimulation Software Forecast
10.4.4 Italy Market Drug Discovery Biosimulation Software Forecast
10.4.5 Russia Market Drug Discovery Biosimulation Software Forecast
10.5 Middle East & Africa Drug Discovery Biosimulation Software Forecast by Region (2026-2031)
10.5.1 Egypt Market Drug Discovery Biosimulation Software Forecast
10.5.2 South Africa Market Drug Discovery Biosimulation Software Forecast
10.5.3 Israel Market Drug Discovery Biosimulation Software Forecast
10.5.4 Turkey Market Drug Discovery Biosimulation Software Forecast
10.6 Global Drug Discovery Biosimulation Software Forecast by Type (2026-2031)
10.7 Global Drug Discovery Biosimulation Software Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Drug Discovery Biosimulation Software Forecast
11 Key Players Analysis
11.1 Biolauncher
11.1.1 Biolauncher Company Information
11.1.2 Biolauncher Drug Discovery Biosimulation Software Product Offered
11.1.3 Biolauncher Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Biolauncher Main Business Overview
11.1.5 Biolauncher Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Drug Discovery Biosimulation Software Product Offered
11.2.3 Pfizer Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Dassault Systemes
11.3.1 Dassault Systemes Company Information
11.3.2 Dassault Systemes Drug Discovery Biosimulation Software Product Offered
11.3.3 Dassault Systemes Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Dassault Systemes Main Business Overview
11.3.5 Dassault Systemes Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Drug Discovery Biosimulation Software Product Offered
11.4.3 Novartis Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Schrodinger
11.5.1 Schrodinger Company Information
11.5.2 Schrodinger Drug Discovery Biosimulation Software Product Offered
11.5.3 Schrodinger Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Schrodinger Main Business Overview
11.5.5 Schrodinger Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Drug Discovery Biosimulation Software Product Offered
11.6.3 AstraZeneca Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Insilico Medicine
11.7.1 Insilico Medicine Company Information
11.7.2 Insilico Medicine Drug Discovery Biosimulation Software Product Offered
11.7.3 Insilico Medicine Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Insilico Medicine Main Business Overview
11.7.5 Insilico Medicine Latest Developments
11.8 Simulations Plus
11.8.1 Simulations Plus Company Information
11.8.2 Simulations Plus Drug Discovery Biosimulation Software Product Offered
11.8.3 Simulations Plus Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Simulations Plus Main Business Overview
11.8.5 Simulations Plus Latest Developments
11.9 Molecular Networks
11.9.1 Molecular Networks Company Information
11.9.2 Molecular Networks Drug Discovery Biosimulation Software Product Offered
11.9.3 Molecular Networks Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Molecular Networks Main Business Overview
11.9.5 Molecular Networks Latest Developments
11.10 Evotec
11.10.1 Evotec Company Information
11.10.2 Evotec Drug Discovery Biosimulation Software Product Offered
11.10.3 Evotec Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Evotec Main Business Overview
11.10.5 Evotec Latest Developments
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Information
11.11.2 Boehringer Ingelheim Drug Discovery Biosimulation Software Product Offered
11.11.3 Boehringer Ingelheim Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Boehringer Ingelheim Main Business Overview
11.11.5 Boehringer Ingelheim Latest Developments
11.12 Certara
11.12.1 Certara Company Information
11.12.2 Certara Drug Discovery Biosimulation Software Product Offered
11.12.3 Certara Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Certara Main Business Overview
11.12.5 Certara Latest Developments
11.13 Tencent AI Lab
11.13.1 Tencent AI Lab Company Information
11.13.2 Tencent AI Lab Drug Discovery Biosimulation Software Product Offered
11.13.3 Tencent AI Lab Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Tencent AI Lab Main Business Overview
11.13.5 Tencent AI Lab Latest Developments
11.14 PharmaResources
11.14.1 PharmaResources Company Information
11.14.2 PharmaResources Drug Discovery Biosimulation Software Product Offered
11.14.3 PharmaResources Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 PharmaResources Main Business Overview
11.14.5 PharmaResources Latest Developments
11.15 Quantum Hi-Tech (China) Biotechnology
11.15.1 Quantum Hi-Tech (China) Biotechnology Company Information
11.15.2 Quantum Hi-Tech (China) Biotechnology Drug Discovery Biosimulation Software Product Offered
11.15.3 Quantum Hi-Tech (China) Biotechnology Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Quantum Hi-Tech (China) Biotechnology Main Business Overview
11.15.5 Quantum Hi-Tech (China) Biotechnology Latest Developments
11.16 Leto Laboratories
11.16.1 Leto Laboratories Company Information
11.16.2 Leto Laboratories Drug Discovery Biosimulation Software Product Offered
11.16.3 Leto Laboratories Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Leto Laboratories Main Business Overview
11.16.5 Leto Laboratories Latest Developments
11.17 Zuoshouyisheng
11.17.1 Zuoshouyisheng Company Information
11.17.2 Zuoshouyisheng Drug Discovery Biosimulation Software Product Offered
11.17.3 Zuoshouyisheng Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Zuoshouyisheng Main Business Overview
11.17.5 Zuoshouyisheng Latest Developments
11.18 Taimei Technology
11.18.1 Taimei Technology Company Information
11.18.2 Taimei Technology Drug Discovery Biosimulation Software Product Offered
11.18.3 Taimei Technology Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Taimei Technology Main Business Overview
11.18.5 Taimei Technology Latest Developments
11.19 AIxplorerbio
11.19.1 AIxplorerbio Company Information
11.19.2 AIxplorerbio Drug Discovery Biosimulation Software Product Offered
11.19.3 AIxplorerbio Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 AIxplorerbio Main Business Overview
11.19.5 AIxplorerbio Latest Developments
11.20 Moore Threads
11.20.1 Moore Threads Company Information
11.20.2 Moore Threads Drug Discovery Biosimulation Software Product Offered
11.20.3 Moore Threads Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Moore Threads Main Business Overview
11.20.5 Moore Threads Latest Developments
11.21 StoneWise
11.21.1 StoneWise Company Information
11.21.2 StoneWise Drug Discovery Biosimulation Software Product Offered
11.21.3 StoneWise Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 StoneWise Main Business Overview
11.21.5 StoneWise Latest Developments
11.22 NovaX Biotech
11.22.1 NovaX Biotech Company Information
11.22.2 NovaX Biotech Drug Discovery Biosimulation Software Product Offered
11.22.3 NovaX Biotech Drug Discovery Biosimulation Software Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 NovaX Biotech Main Business Overview
11.22.5 NovaX Biotech Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.